The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: A meta-analysis

被引：0
|
作者：
Iacoviello, L [1 ]
Burzotta, F
Di Castelnuovo, A
Zito, F
Marchioli, R
Donati, MB
机构：
[1] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Angela Valenti Lab Thrombosis Pharmacol, Dept Vasc Med & Pharm,Un Gen Vasc Risk Fact, I-66030 Santa Maria Imbaro, Italy
[2] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Lab Clin Epidemiol Cardiovasc Dis, I-66030 Santa Maria Imbaro, Italy
[3] TNO, PG, Gaubius Lab, Leiden, Netherlands
来源：
THROMBOSIS AND HAEMOSTASIS | 1998年 / 80卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1029 / 1030
页数：2
相关论文
共 50 条
  • [1] The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: A meta-analysis
    Di Castelnuovo, A
    Burzotta, F
    Marchioli, R
    Donati, MB
    Iacoviello, L
    THROMBOSIS RESEARCH, 1998, 91 (03) : S104 - S105
  • [2] PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis
    Liang, Zhongshu
    Jiang, Weihong
    Ouyang, Mao
    Yang, Kan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (02): : 2097 - 2107
  • [3] PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction
    Leander, K
    Wiman, B
    Hallqvist, J
    Sten-Linder, M
    de Faire, U
    THROMBOSIS AND HAEMOSTASIS, 2003, 89 (06) : 1064 - 1071
  • [4] Diabetic microangiopathy and 4G/5G polymorphism of the PAI-1 gene promoter in IDDM
    Pucci, L
    Pilo, M
    Bandinelli, S
    Navalesi, R
    Penno, G
    DIABETES, 1999, 48 : A153 - A153
  • [5] 4G/5G polymorphism in the promoter region of the PAI-1 gene is not a risk factor for familial myocardial infarction in subjects over 45 years
    Burzotta, F
    DiCastelnuovo, A
    Amore, C
    DOrazio, A
    Donati, MB
    Iacoviello, L
    THROMBOSIS AND HAEMOSTASIS, 1997, 78 (04) : 1294 - 1295
  • [6] Relation between osteonecrosis of the femoral head and PAI-1 4G/5G gene polymorphism: a meta-analysis
    Zeng, Zheng
    Wang, Bing
    Pan, Haitao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 20337 - 20342
  • [7] The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women
    Hindorff, LA
    Schwartz, SM
    Siscovick, DS
    Psaty, BM
    Longstreth, WT
    Reiner, AP
    JOURNAL OF CARDIOVASCULAR RISK, 2002, 9 (02): : 131 - 137
  • [8] An alternative method for PAI-1 promoter polymorphism (4G/5G) typing
    Margaglione, M
    Grandone, E
    Cappucci, G
    Colaizzo, D
    Giuliani, N
    Vecchione, G
    dAddedda, M
    DiMinno, G
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (03) : 605 - 606
  • [9] The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis
    Nikolopoulos, Georgios K.
    Bagos, Pantelis G.
    Tsangaris, Iraklis
    Tsiara, Chrissa G.
    Kopterides, Petros
    Vaiopoulos, Aristides
    Kapsimali, Violetta
    Bonovas, Stefanos
    Tsantes, Argirios E.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (07) : 937 - 950
  • [10] PAI-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence from Meta-Analysis
    Wang, Shangqian
    Cao, Qiang
    Wang, Xiaoxiang
    Li, Bingjie
    Tang, Min
    Yuan, Wanqing
    Fang, Jianzheng
    Qian, Jian
    Qin, Chao
    Zhang, Wei
    PLOS ONE, 2013, 8 (02):
12345